IP Verse

Adalvo patent opposition analysis

Get complete Patent Opposition Report for Adalvo

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Adalvo

Explore patent oppositions filed by Adalvo against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3474820	Glp-1 Compositions And Uses Thereof	NOVO NORDISK	Nov 7, 2024
EP3999643	Methods Of Treating Or Preventing Spinal Muscular Atrophy	BIOGEN MA	Aug 22, 2024
EP3542790	Compositions Comprising A Delivery Agent And Preparation Thereof	NOVO NORDISK	Jun 13, 2024
EP3697392	Tablets Comprising Tamsulosin And Solifenacin	SYNTHON	Jan 23, 2024
EP3283058	Ribociclib Tablet	NOVARTIS	Aug 15, 2023
EP2981255	Therapeutic Uses Of Empagliflozin	BOEHRINGER INGELHEIM	Jun 13, 2023
EP3448416	Semaglutide In Cardiovascular Conditions	NOVO NORDISK	May 9, 2023
EP2653873	Compositions And Uses For Treating Multiple Sclerosis	BIOGEN IDEC MA	Apr 14, 2023
EP3632448	Pharmaceutical Composition Comprising Drospirenone And Contraceptive Kit	LABORATORIOS LEON FARMA	Oct 12, 2022
EP3423082	Liraglutide In Cardiovascular Conditions	NOVO NORDISK	May 3, 2022

Latest patents of Adalvo opposed by its competitors

Explore Adalvo's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3845215	Jul 27, 2022	Oral Solutions Comprising Lisdexamfetamine Salts	1

Top competitors of Adalvo

NOVO NORDISK

BIOGEN MA

ALKERMES PHARMA IRELAND